Switch theme
Sign up to access all valuation multiples
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.
2012
4
Last FY Revenue $0.1M
Last FY EBITDA -$1.2M
$12.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Medinice achieved revenue of $0.1M and an EBITDA of -$1.2M.
Medinice expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Medinice valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.1M | XXX | XXX | XXX |
| Gross Profit | XXX | $20K | XXX | XXX | XXX |
| Gross Margin | XXX | 33% | XXX | XXX | XXX |
| EBITDA | XXX | -$1.2M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -2068% | XXX | XXX | XXX |
| EBIT | XXX | -$1.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | -2577% | XXX | XXX | XXX |
| Net Profit | XXX | -$1.3M | XXX | XXX | XXX |
| Net Margin | XXX | -2254% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Medinice's stock price is PLN 7 (or $2).
Medinice has current market cap of PLN 53.4M (or $14.2M), and EV of PLN 47.2M (or $12.5M).
See Medinice trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12.5M | $14.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Medinice has market cap of $14.2M and EV of $12.5M.
Medinice's trades at 209.6x EV/Revenue multiple, and -10.1x EV/EBITDA.
Equity research analysts estimate Medinice's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medinice's P/E ratio is not available.
See valuation multiples for Medinice and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $14.2M | XXX | $14.2M | XXX | XXX | XXX |
| EV (current) | $12.5M | XXX | $12.5M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 209.6x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -10.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -8.1x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -10.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -4.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedinice's revenue per employee in the last FY averaged $15K, while opex per employee averaged $0.4M for the same period.
Medinice's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medinice's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Medinice and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -2068% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $15K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 2611% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medinice acquired XXX companies to date.
Last acquisition by Medinice was XXXXXXXX, XXXXX XXXXX XXXXXX . Medinice acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Medinice founded? | Medinice was founded in 2012. |
| Where is Medinice headquartered? | Medinice is headquartered in Poland. |
| How many employees does Medinice have? | As of today, Medinice has 4 employees. |
| Is Medinice publicy listed? | Yes, Medinice is a public company listed on WAR. |
| What is the stock symbol of Medinice? | Medinice trades under ICE ticker. |
| When did Medinice go public? | Medinice went public in 2018. |
| Who are competitors of Medinice? | Similar companies to Medinice include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Medinice? | Medinice's current market cap is $14.2M |
| Is Medinice profitable? | Yes, Medinice is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
